.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Imipramine hydrochloride - Generic Drug Details

« Back to Dashboard
Imipramine hydrochloride is the generic ingredient in five branded drugs marketed by Sandoz, Leading Pharma Llc, Vangard, Watson Labs, Par Pharm, West Ward, Alra, Teva, Sanofi Aventis Us, Novartis, Lupin Ltd, Mallinckrodt Inc, Sun Pharm Inds, Oxford Pharms, Lederle, Usl Pharma, Abbott, and Roxane, and is included in forty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-four drug master file entries for imipramine hydrochloride. Twenty suppliers are listed for this compound.

Summary for Generic Name: imipramine hydrochloride

Tradenames:5
Patents:0
Applicants:18
NDAs:44
Drug Master File Entries: see list34
Suppliers / Packaging: see list20
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: imipramine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva
IMIPRAMINE HYDROCHLORIDE
imipramine hydrochloride
TABLET;ORAL083729-004Approved Prior to Jan 1, 1982DISCNNo► subscribe► subscribe
Abbott
JANIMINE
imipramine hydrochloride
TABLET;ORAL017895-002Approved Prior to Jan 1, 1982DISCNNo► subscribe► subscribe
Sanofi Aventis Us
PRESAMINE
imipramine hydrochloride
TABLET;ORAL011836-006Approved Prior to Jan 1, 1982DISCNNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc